WO2018154608A3 - Herbo-mineral formulation for the treatment of cardio vascular diseases and method of preparation thereof - Google Patents

Herbo-mineral formulation for the treatment of cardio vascular diseases and method of preparation thereof Download PDF

Info

Publication number
WO2018154608A3
WO2018154608A3 PCT/IN2018/050102 IN2018050102W WO2018154608A3 WO 2018154608 A3 WO2018154608 A3 WO 2018154608A3 IN 2018050102 W IN2018050102 W IN 2018050102W WO 2018154608 A3 WO2018154608 A3 WO 2018154608A3
Authority
WO
WIPO (PCT)
Prior art keywords
vascular diseases
herbo
treatment
cardio vascular
preparation
Prior art date
Application number
PCT/IN2018/050102
Other languages
French (fr)
Other versions
WO2018154608A2 (en
Inventor
Dr. M Vijayabhanu SHETTY
Original Assignee
Muniyal Ayurvedic Research Centre
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Muniyal Ayurvedic Research Centre filed Critical Muniyal Ayurvedic Research Centre
Priority to BR112019017594-6A priority Critical patent/BR112019017594A2/en
Priority to JP2019545922A priority patent/JP2020512301A/en
Priority to EP18757495.9A priority patent/EP3585407A4/en
Priority to AU2018223381A priority patent/AU2018223381A1/en
Priority to RU2019130384A priority patent/RU2019130384A/en
Priority to CA3054271A priority patent/CA3054271A1/en
Priority to KR1020197027909A priority patent/KR20190132388A/en
Priority to CN201880014283.1A priority patent/CN110891585A/en
Publication of WO2018154608A2 publication Critical patent/WO2018154608A2/en
Publication of WO2018154608A3 publication Critical patent/WO2018154608A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Herbo-mineral Formulation for the treatment of Cardio vascular diseases and method of preparing the same are disclosed herein. The disclosed herbo-mineral formulation includes herb and mineral components which facilitate in treating Cardio vascular diseases. Cardio vascular diseases may include any condition associated with heart and blood vessels. Further, the disclosed formulation may also be instrumental as anti-oxidating, anti-stress, hypolipidemic, atherogenic, antihypertensive, apoptotsis inhibiting and cardio-protective agent.
PCT/IN2018/050102 2017-02-27 2018-02-27 Herbo-mineral formulation for the treatment of cardio vascular diseases and method of preparation thereof WO2018154608A2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
BR112019017594-6A BR112019017594A2 (en) 2017-02-27 2018-02-27 HERBO-MINERAL FORMULATION FOR TREATMENT AND CONTROL OF CARDIOVASCULAR DISEASES, USE AND PROCESS FOR THE PREPARATION OF THE SAME
JP2019545922A JP2020512301A (en) 2017-02-27 2018-02-27 Herbal and mineral preparations for the treatment of cardiovascular diseases and methods for their preparation
EP18757495.9A EP3585407A4 (en) 2017-02-27 2018-02-27 Herbo-mineral formulation for the treatment of cardio vascular diseases and method of preparation thereof
AU2018223381A AU2018223381A1 (en) 2017-02-27 2018-02-27 Herbo-mineral formulation for the treatment of cardio vascular diseases and method of preparation thereof
RU2019130384A RU2019130384A (en) 2017-02-27 2018-02-27 PREPARATION BASED ON MEDICINAL PLANTS AND MINERALS FOR TREATMENT OF CARDIOVASCULAR DISEASES AND METHOD FOR ITS PRODUCTION
CA3054271A CA3054271A1 (en) 2017-02-27 2018-02-27 Herbo-mineral formulation for the treatment of cardio vascular diseases and method of preparation thereof
KR1020197027909A KR20190132388A (en) 2017-02-27 2018-02-27 Hebo-mineral preparation for cardiovascular disease treatment and preparation method thereof
CN201880014283.1A CN110891585A (en) 2017-02-27 2018-02-27 Herbal-mineral formulation for treating cardiovascular disease and method for preparing the same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201741006955 2017-02-27
IN201741006955 2017-02-27

Publications (2)

Publication Number Publication Date
WO2018154608A2 WO2018154608A2 (en) 2018-08-30
WO2018154608A3 true WO2018154608A3 (en) 2018-11-01

Family

ID=63254299

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2018/050102 WO2018154608A2 (en) 2017-02-27 2018-02-27 Herbo-mineral formulation for the treatment of cardio vascular diseases and method of preparation thereof

Country Status (9)

Country Link
EP (1) EP3585407A4 (en)
JP (1) JP2020512301A (en)
KR (1) KR20190132388A (en)
CN (1) CN110891585A (en)
AU (1) AU2018223381A1 (en)
BR (1) BR112019017594A2 (en)
CA (1) CA3054271A1 (en)
RU (1) RU2019130384A (en)
WO (1) WO2018154608A2 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7416743B2 (en) * 2002-01-13 2008-08-26 Department Of Biotechnology Polyherbal preparation for the prevention of atherosclerosis and hyperlipidemia
US20100021533A1 (en) * 2008-04-07 2010-01-28 Mazed Mohammad A Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance
US20100173022A1 (en) * 2007-03-23 2010-07-08 Devindra Ramautarsing Composition for the treatment of diabetes mellitus and metabolic syndrome
US8895075B2 (en) * 2007-09-20 2014-11-25 Atul M. Desai Herbomineral formulation for treating sickle cell disease
US8962576B2 (en) * 2012-03-30 2015-02-24 Natreon, Inc. Compositions and method for improving endothelial function and cardiovascular health
US20180236018A1 (en) * 2017-04-24 2018-08-23 Muniyal Ayurvedic Research Centre Herbo-mineral formulation for prevention, treatment and management of diabetes and method of preparation thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2393503B1 (en) * 2009-02-04 2016-09-07 Sharma, Anurag Ayurvedic formulation for treating coronary heart disease
WO2012020422A1 (en) * 2010-08-09 2012-02-16 Interdisciplinary School Of Indian System Of Medicine A novel herbal formulation advocated for the prevention and management of coronary heart disease

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7416743B2 (en) * 2002-01-13 2008-08-26 Department Of Biotechnology Polyherbal preparation for the prevention of atherosclerosis and hyperlipidemia
US20100173022A1 (en) * 2007-03-23 2010-07-08 Devindra Ramautarsing Composition for the treatment of diabetes mellitus and metabolic syndrome
US8895075B2 (en) * 2007-09-20 2014-11-25 Atul M. Desai Herbomineral formulation for treating sickle cell disease
US20100021533A1 (en) * 2008-04-07 2010-01-28 Mazed Mohammad A Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance
US8962576B2 (en) * 2012-03-30 2015-02-24 Natreon, Inc. Compositions and method for improving endothelial function and cardiovascular health
US20180236018A1 (en) * 2017-04-24 2018-08-23 Muniyal Ayurvedic Research Centre Herbo-mineral formulation for prevention, treatment and management of diabetes and method of preparation thereof

Also Published As

Publication number Publication date
RU2019130384A (en) 2021-03-29
CA3054271A1 (en) 2018-08-30
WO2018154608A2 (en) 2018-08-30
JP2020512301A (en) 2020-04-23
BR112019017594A2 (en) 2020-03-24
KR20190132388A (en) 2019-11-27
CN110891585A (en) 2020-03-17
AU2018223381A1 (en) 2019-10-17
EP3585407A2 (en) 2020-01-01
EP3585407A4 (en) 2021-01-20

Similar Documents

Publication Publication Date Title
WO2018042438A3 (en) Human blood-derived products having decreased fibrinolytic activity and uses thereof in hemostatic disorders
WO2016025635A3 (en) Combination therapy for treating cancer
PH12018502634A1 (en) Topical compositions of apremilast
PH12020551043A1 (en) Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues
SG10201902664RA (en) Combination therapy for treating cancer
WO2017079570A3 (en) Splise-switching oligonucleotides and methods of use
WO2016043874A3 (en) Combination therapy for treating cancer
WO2015191934A8 (en) Blood-brain barrier (bbb) penetrating dual specific binding proteins for treating brain and neurological diseases
MX2018004616A (en) Cosmetic composition having probiotic bacteria.
FR2969495B1 (en) EXTRACT OF MACA-RICH AERIAL PARTS OF POLYPHENOLS AND COMPOSITION COMPRISING THE SAME
EP3488877A4 (en) Implant and kit for treatment of bone lesion site, as well as method for treating bone lesion site
EP4279128A3 (en) Novel antibody binding to tfpi and composition comprising the same
WO2018038988A3 (en) Imidazo[1,2-a]pyridin compounds, compositions comprising them, methods for treating diseases using them, and methods for preparing them
MX2018002546A (en) Compositions comprising an urolithin compound.
EP4092031A4 (en) Azabicyclic substituted oxaspiro derivative, preparation method therefor and medical use thereof
PH12020551071A1 (en) Compositions and methods for treating retinal disorders
EP4295906A3 (en) Treatment of restenosis using temsirolimus
WO2017121646A8 (en) 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
WO2016181220A3 (en) Therapeutic compositions comprising a combination from a curcumin, a harmine and isovanillin component and methods of use thereof
EP3476395A4 (en) Composition for injection which can be used for treatment of heart diseases and contains fibroblasts, and method for producing fibroblast for therapy use
WO2014116015A3 (en) Composition for preventing alzheimer's disease, containing purple bamboo salt, and method for preparing purple bamboo salt
WO2019232203A3 (en) Methods and compositions to alleviate vascular permeability
WO2018154608A3 (en) Herbo-mineral formulation for the treatment of cardio vascular diseases and method of preparation thereof
EP3781262A4 (en) Compositions and methods for treating cardiovascular disease in selected patients
MX2022013681A (en) Methods and compositions for treatment of hypercalciuria and nephrolithiasis.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18757495

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 3054271

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2019545922

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112019017594

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 20197027909

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2018757495

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2018223381

Country of ref document: AU

Date of ref document: 20180227

Kind code of ref document: A

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18757495

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 112019017594

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20190823